Semaglutide, including its brand names like Ozempic and Mounjaro, is generally well-tolerated, but like all medications, it can have potential side effects, some of which may indirectly impact a womans menstrual cycle
Retatrutide achieved higher numbers in less time, but the populations and trial designs differed
All GLP-1 receptor agonists affect gut motility to some degree, with important differences in their frequency and severity of digestive side effects
This makes it one of the most widely studied weight-loss drugs currently in use in the medical field
(1998) for the original description of Ipamorelin as a selective GHRP
The UK Summary of Product Characteristics (SmPC) for semaglutide does not list hypothyroidism as a contraindication, and clinical trials included participants with thyroid disorders